show episodes
 
The Compass Opioid Stewardship Clinical Cases podcast aims to provide clinicians with practical skills for managing patients on chronic opioid therapy. This 11 part podcast series introduces a framework to approaching clinical encounters with legacy patients on long term opioid therapy. Episodes highlight clinical patient scenarios through roleplaying and are followed by a discussion of the science, structure and pertinent clinical skills by Board Certified Addiction Medicine physician Dr. D ...
  continue reading
 
Artwork
 
The Compass Opioid Stewardship Program aims to combat the opioid epidemic through education. The program aims to accomplish the following goals: 1. Educate and provide outreach to outlier prescribers of opioids about best practices for prescribing opioids 2. Educate and provide outreach to outlier prescribers of opioids about non-opioid pain management therapies 3. Reduce the amount of opioid prescriptions prescribed by eligible prescribers
  continue reading
 
Artwork
 
This podcast aims to bring light to Colorado's CURES Opioid Prescribing Guidelines for different clinical specialities through interviews with specialists. In 2019, Colorado Hospital Association, Colorado Medical Society and Colorado Consortium for Prescription Drug Abuse Prevention launched a new initiative designed to address the opioid epidemic – Colorado’s Opioid Solution: Clinicians United to Resolve the Epidemic (CO’s CURE). CO’s CURE brought together diverse clinical specialties, all ...
  continue reading
 
Artwork
 
The Compass Opioid Stewardship Program aims to combat the opioid epidemic through education. The program aims to accomplish the following goals: 1. Educate and provide outreach to outlier prescribers of opioids about best practices for prescribing opioids 2. Educate and provide outreach to outlier prescribers of opioids about non-opioid pain management therapies 3. Reduce the amount of opioid prescriptions prescribed by eligible prescribers
  continue reading
 
Artwork

1
The Curbsiders Addiction Medicine Podcast

The Curbsiders Addiction Medicine Podcast

Unsubscribe
Unsubscribe
Monthly
 
SEASON 3 will launch July 18th, 2024! Step up your knowledge on caring for patients with substance use disorders (SUD)! This show features addiction medicine experts who are dedicated to bringing you practice changing knowledge about substance use, and substance use disorders. We use expert interviews to demystify common addiction medicine topics, reduce stigma, and inspire listeners to be fierce advocates for all individuals who use substances. This mini-series is hosted by Doctors Carolyn ...
  continue reading
 
Artwork

1
Perioperative Medicine Podcast Series

Monash University - Department of Anaesthesiology and Perioperative Medicine.

Unsubscribe
Unsubscribe
Monthly
 
Perioperative Medicine Short Course is conducted by Monash University (Central Clinical School - Alfred Hospital), in conjunction with the Alfred Hospital and Department of Anaesthesiology and Perioperative Medicine. As part of our drive to improve and promote perioperative medicine education we are launching our PeriopMed podcast series.
  continue reading
 
Medication-assisted treatment for opioid use disorder works. Suboxone is a brand name for sublingual buprenorphine and naloxone, the gold standard of treatment for opioid dependence. This podcast addresses issues relating to opioid addiction, including fentanyl, heroin, and pain pill misuse, and how to help people overcome opioid addiction with the help of medication assisted treatment.
  continue reading
 
Discussion of substance abuse, addiction, health issues and risks associated with addiction. Podcast designed to educate, inform, guide, and explain everything related to substance abuse and addiction and how to overcome it. I discuss alcohol and drug addiction, symptoms of addiction, the withdrawal process as well as ways to find sobriety. Whether you're struggling with addiction or have a loved one you're concerned about or want to learn about addiction, this podcast is the right place for ...
  continue reading
 
Artwork

1
Addiction Medicine: Beyond the Abstract

American Society of Addiction Medicine

Unsubscribe
Unsubscribe
Monthly
 
An ideal opportunity for those interested in addiction medicine to get a closer look at the perspectives behind formal research articles. Podcasts offer insights into the experiences of the authors and researchers behind the great work and development in the field. Listening to their stories and thought processes helps listeners to connect with the experts behind the journal in a brand-new way. Hosted by Journal Podcast Editor, Shawn McNeil, MD
  continue reading
 
Listen to 15-20 minute long interviews of experts on various topics related to mental and general health. The topics will be continuously expanded. The interviews are designed for both professionals and non-professionals. Topics range from climate change issues and the basis of new medication research, COVID-19 issues, the effect of media on girls's self-images, discussions of violence, same-sex marriages, pollution, bullying, divorce, OCD, addictions, borderline personality disorders, menta ...
  continue reading
 
Artwork
 
The Addiction Medicine Podcast is designed for healthcare professionals and others interested in addiction medicine and will feature thoughtful conversations and insights from clinicians, patients and families, policymakers and other stakeholders.
  continue reading
 
Artwork
 
Learn more about pain states that are often dismissed such as fibromyalgia and headache. This podcast is a resource to better understand pain, why we hurt, and what we can do about it. We discuss the latest information and ideas for pain control strategies and treatment. I've been actively practicing pain medicine for nearly four decades. Please note the information in this podcast is not medical advice. Want to learn more about pain, addiction and depression? Visit us signatureclinics.com
  continue reading
 
PAINWeek is the preferred resource for frontline practitioners treating acute and chronic pain. For over a decade, we have demonstrated that “education is the best analgesic’’ by presenting over 12,000 hours of content across our national and regional conferences, conducting hundreds of Expert Opinion interviews, and publishing an array of faculty authored articles in our quarterly journal. Be it live, digital, or print, PAINWeek provides education and insight 365 days/year!
  continue reading
 
Artwork

1
Recovery Connection

pod617 - The Boston Podcast Network

Unsubscribe
Unsubscribe
Monthly
 
Welcome to Recovery Connections podcast. This show provides information about helping you in substance abuse treatment. We know that this is not an easy process and there's a lot of differing information out there. And if we can give you our philosophy and the way we see the world out there, perhaps it wll be helpful to you or at least begin your process of seeking information and help. With host Michael Brier, CEO of Recovery Connection, and Greg Graustein, chief clinical director. For more ...
  continue reading
 
Loading …
show series
 
OTP yea you know me Make methadone a part of your practice. Learn how the methadone system in the US works and how you can play an active role in improving care for people with opioid use disorder treated with methadone. We’re joined by Dr. Ruth Potee @DrRuthPotee (website) and Dr. David Frank @highway_dave Claim free CME for this episode at curbsi…
  continue reading
 
45. Urine Drug Screens and Treatment Retention In episode 45 we discuss urine drug screens and treatment retention. Michener PS, Knee A, Wilson D, Boama-Nyarko E, Friedmann PD. Association of random and observed urine drug screening with long-term retention in opioid treatment programs. Drug Alcohol Depend. 2024 Feb 1;255:111067. We also discuss st…
  continue reading
 
In this essential episode, we tackle the critical topic of discontinuing Suboxone treatment, comparing the risky "cold turkey" approach with safer tapering methods. Discover why addiction medicine specialists caution against abrupt cessation and learn about the potential physical and psychological impacts of sudden Suboxone withdrawal. We explore t…
  continue reading
 
Rachel Earls, Ph.D., outlines the roles, science, and limitations of this powerful clinical tool for the selection of medication. They guide us on how a person metabolizes many medications, and so it helps get proper doses for better efficacy and fewer side effects. It does not predict outcome, but greatly assists with treatment choices. She speaks…
  continue reading
 
44. Cannabis and CV Outcomes In episode 44 we discuss the association between cannabis use and cardiovascular outcomes. Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of Cannabis Use With Cardiovascular Outcomes Among US Adults. J Am Heart Assoc. 2024 Mar 5;13(5):e030178. doi: 10.1161/JAHA.123.030178. Epub 2024 Feb 28. We also discuss the D…
  continue reading
 
In episode 43 we discuss prescribing medication for alcohol use disorder at hospital discharge. Bernstein EY, Et al. Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge. JAMA Netw Open. 2024 Mar 4;7(3):e243387. We also discuss grandparents raising grandchildren who’ve lost a parent to drug overdose, and how nativ…
  continue reading
 
Podcast host Shawn McNiel, MD, is joined by Noa Krawczyk, PhD, an assistant professor in the Department of Population Health at NYU Grossman School of Medicine, and an author of Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals. D…
  continue reading
 
In this episode of "What's the Proof?" we delve into non-hormonal therapies for menopausal vasomotor symptoms (VMS), commonly known as hot flashes and night sweats. Hormone replacement therapy (HRT) is the most effective treatment for VMS, but it isn't suitable for everyone. Join Bobby, Dawn, and Sandy as they explore alternative treatment options …
  continue reading
 
In episode 42 we discuss how buprenorphine protects against fentanyl overdose. Zheng Dai, et al. Quantifying a potential protective effect of buprenorphine on fatality risk during acute fentanyl exposures. Journal of Substance Use and Addiction Treatment, Volume 158, 2024. 209252, ISSN 2949-8759. We also discuss semaglutide for alcohol use disorder…
  continue reading
 
In episode 41 we discuss vaping for smoking cessation. Auer R, et al. Electronic Nicotine-Delivery Systems for Smoking Cessation. N Engl J Med. 2024 Feb 15;390(7):601-610. We also discuss the NarxCare addiction risk score and the recent increase in alcohol-related deaths. New York Times: Addiction Risk Scores Won’t Solve the Opioid Crisis CDC: Deat…
  continue reading
 
Quick summaries of Episodes 31-40. 31. Injection Drug Use Frequency Before and After Take-Home Naloxone Training 32. Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: A double blind, placebo-controlled trial 33. Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medica…
  continue reading
 
Stuart Isaacson, M.D., neurologist, explains TD, the role of dopamine in psychiatric and then this treatment induced consequential movement disorder, proper diagnosis, how both psychiatric and neurologic treatments are very helpful, but he also weighs the risk-benefits of now the increasing use of antipsychotics for mood disorders. He further talks…
  continue reading
 
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022 Host Shawn McNiel, MD, is joined by Marissa Tan, DO, an Epidemiology Intelligence Service (EIS) Fellow for the Center of Disease Control and Prevention through the Philadelphia Department of Public Health. Dr. Tan and her co-authors sought to help clinicians better identify individuals a…
  continue reading
 
In this episode we discuss drug overdose after benzodiazepine prescriptions for anxiety and depression. Bushnell GA, et al. Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals. Addiction. 2023. We also talk about the war on recovery treatments and patients leaving the …
  continue reading
 
The ASCVD Risk Estimator is OUT and PREVENT is IN! Join us on this episode of 'What's the Proof?' where hosts Bobby Scott and Sandy Robertson explore the American Heart Association's revolutionary PREVENT calculator. This new tool not only replaces outdated risk calculators but also introduces the comprehensive Cardiovascular-Kidney-Metabolic (CKM)…
  continue reading
 
In this episode we discuss improvements in cognitive function with opioid abstinence. Kaur, G. Et Al. Effects of Abstinence From Opioid on Neuropsychological Performance in Men With Opioid Use Disorder: A Longitudinal Study. Journal of Addiction Medicine 17(5): p 557-562, 9/10 2023. We also talk about paramedics giving buprenorphine along with nalo…
  continue reading
 
In this episode we discuss 5 more articles that changed our addiction medicine practice. Chambers LC, et al. Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl. JAMA Netw Open. 2023; 6(9):e2334540. September 2023. (Episode 34) Caponnetto, P., et al. Varenicline and counseling for vaping ces…
  continue reading
 
Episode 16 is our first interview episode. Dr. T joined us in the studio to talk about medications used in addiction medicine, such as Buprenorphine, Naltrexone and Phenobarbital. What are these medications and what are they prescribed for? Who can take them and when? Listen now to get the answers to these questions and many more!…
  continue reading
 
A Just Culture in the workplace means that everyone should feel safe to speak up, and leads to open and honest communication, systems thinking, engagement, and participation, where everyone is involved in making improvements. Professor Janet Anderson and Garry Mann, our Human Factors team, talk to Yooralla’s Director of Just Culture Miranda Corneli…
  continue reading
 
In this episode we discuss 5 articles that changed our addiction medicine practice. Mahdi Sheikh, et al. Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality: A Prospective Cohort Study. Ann Intern Med.2021;174:1232-1239. [Epub 27 July 2021]. (Episode 4) Santos GM, et al. Targeted Oral Naltrexone for Mild to Mo…
  continue reading
 
In episode 38 we discuss an article comparing different treatments (and no treatment) for opioid use disorder. Robert Heimer, Anne C. Black, Hsiuju Lin, Lauretta E. Grau, David A. Fiellin, Benjamin A. Howell, Kathryn Hawk, Gail D’Onofrio, William C. Becker. Receipt of Opioid Use Disorder Treatments Prior to Fatal Overdoses and Comparison to No Trea…
  continue reading
 
37. Injectable Vs. Sublingual Buprenorphine In episode 37 we discuss an article comparing injectable and sublingual buprenorphine. Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial. Marsden…
  continue reading
 
Podcast host Shawn McNeil, MD, is joined by Joshua Sharfstein, MD, and Sara Whaley, MPH, from Johns Hopkins Bloomberg School of Public Health who delve into the strategic allocation of $56 billion from opioid litigation settlements. As they discuss the principles for effective fund utilization, they highlight opportunities for addiction medicine sp…
  continue reading
 
In episode 36 we discuss an article about the mediators of problematic smartphone use. Christiane Arrivillaga, Caleb J. Hallauer, Christian Montag, Jon D. Elhai. Emotion dysregulation factors associated with problematic smartphone use severity: The mediating role of fear of missing out. Addictive Behaviors. Volume 143. 2023. https://doi.org/10.1016…
  continue reading
 
In episode 35 we discuss whether eliminating prior auths leads to more buprenorphine prescribing. Christine PJ, Larochelle MR, Lin L, McBride J, Tipirneni R. Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder. JAMA Health Forum. 2023;4(10):e233549. We also discuss buprenorphine diversion, and th…
  continue reading
 
Have you ever tried finding a needle in a haystack? Can you image how difficult that is? Now imagine having to find seven needles in a haystack to navigate through your everyday life in addiction. And burning down the haystack to find the needles isn't an option, because that would mean overdose and death. Listen now to find out what it means to lo…
  continue reading
 
In episode 24 we discuss prescribing 24 mg of buprenorphine daily. Chambers LC, Hallowell BD, Zullo AR, et al. Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl. JAMA Netw Open. 2023;6(9):e2334540. September 2023. We also discuss why Rite Aid filed for bankruptcy, and the FDA ban on mentho…
  continue reading
 
Any patient undergoing a procedure or intervention should be provided with an explanation of the procedure and the risks involved, and be asked to give their consent. Often this is a process that is poorly done or misunderstood by both of the clinician and the patient. Dr Maryanne Balkin discusses the legal and ethical issues surrounding informed c…
  continue reading
 
In episode 28 of Addiction Medicine: Beyond the Abstract, host Shawn McNeil, MD is joined my Ashish Thakrar, MD, MS, an addiction medicine specialist and Assistant Professor of Medicine with the University of Pennsylvania. Dr. Thakrar discusses the outcome of his research, which aimed to determine whether fentanyl concentration is associated with t…
  continue reading
 
Increasing numbers of older people are undergoing surgery and adverse outcomes are common within this patient group. Dr Margot Lodge is a Geriatrician with a special interest in Perioperative Medicine. She discusses the role of the geriatrician in Perioperative Medicine and the use of implementation science in adopting new models of care for the ol…
  continue reading
 
The Walking Away From Addiction team has created a 5 step program to recovery. Listen to this episode to learn about these steps. Additionally you can find a copy of the pyramid we reference in this episode on our Instagram page @walkingawayfromaddiction. If you want to support our nonprofit organization, or if you have any questions, please reach …
  continue reading
 
"One drug, three doses, one test.” In this episode of 'What's the Proof?', we are joined by our guest, Dr. Bobby Levy, who will be discussing the application of buprenorphine-naloxone in the treatment of opioid use disorder. Discover how personal experiences led Dr. Levy to become a passionate advocate for integrating opioid use disorder treatment …
  continue reading
 
In episode 33 we discuss overdose risk and polypharmacy: opioids, benzodiazepines, antipsychotics, and gabapentinoids. Domzaridou E, Carr MJ, Millar T, Webb RT, Ashcroft DM. Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mor…
  continue reading
 
In episode 32 we discuss an article about trazodone for sleep in people with opioid use disorder on buprenorphine. Piyush Goyal, Dheeraj Kattula, Ravindra Rao, Roshan Bhad, Ashwani Kumar Mishra, Anju Dhawan. Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: A double blind, placebo-controlled trial. Drug and A…
  continue reading
 
Methamphetamine is the most used illicit drug used world wide. But in the last decade the focus in the news has been on the opioid epidemic. Is meth less harmful? Or is it a highly toxic and dangerous substance? Listen now to find out more about meth than you have ever learned before. Walking Away From Addiction is a nonprofit organization. We than…
  continue reading
 
31: We discuss an article about how naloxone training impacts IV drug use. Colledge-Frisby S, Rathnayake K, Nielsen S, et al. Injection Drug Use Frequency Before and After Take-Home Naloxone Training. JAMA Netw Open. 2023;6(8):e2327319. We also discuss gambling self-exclusion and which professions use the most drugs. From the Pennsylvania Gaming Co…
  continue reading
 
We want to thank every single one of your for listening to our podcast! The support we have received has been absolutely incredible. We won't lie, this podcast is a lot of work. But at the same time we have a blast recording these episodes. The three of us have become best friends. Not everything runs smoothly all the time. Join us for this Hallowe…
  continue reading
 
Dr Lana Vestarkis is an Anaesthetist at Sunshine Coast University Hospital. For her Master of Perioperative Medicine Capstone Project, Lana worked with her colleague Dr Anna Pietzsch to attempt to rationalise preoperative blood testing in the elective surgical setting. Their project is not only having a major impact in their health network but has …
  continue reading
 
Quick summaries of Episodes 21-30. 21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder: Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder 22. Contingency Management for Coronary Artery Disease: High-risk Coronary Plaque Regression in Cash-based Conti…
  continue reading
 
The language used to describe people with substance use disorder impacts stigma and influences clinical decision-making. Host Dr. Shawn McNeil, MD discusses with Dr. Scott G. Weiner, MD the presence of stigmatizing language in clinical notes and detects patient- and provider-level differences. ----more---- Based on original research published in th…
  continue reading
 
The language used to describe people with substance use disorder impacts stigma and influences clinical decision-making. Host Dr. Shawn McNeil, MD discusses with Dr. Scott G. Weiner, MD the presence of stigmatizing language in clinical notes and detects patient- and provider-level differences. Based on original research published in the Journal of …
  continue reading
 
Keep saving lives by prescribing methadone and buprenorphine. Learn how initiations of each have changed in the era of high-potency synthetic opioids (HPSOs) like fentanyl and how to continue to provide person-centered care to people with opioid use disorder. We’re joined by Dr Melissa Weimer, @DrMelissaWeimer (Yale University). This episode is in …
  continue reading
 
Loading …

Quick Reference Guide